Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.

80 total trials for this combination

Showing top 10 of 80 trials

Trials

NCT ID	Title	Status	Phase
NCT02065791	Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy	COMPLETED	PHASE3
NCT03819153	A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease	COMPLETED	PHASE3
NCT05514535	A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)	COMPLETED	PHASE3
NCT00968708	Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome	COMPLETED	PHASE3
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT01336023	Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT03811561	A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes	ACTIVE_NOT_RECRUITING	—
NCT02016911	Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment	COMPLETED	PHASE1
NCT01991795	A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus	COMPLETED	PHASE3
NCT03811561	A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes	ACTIVE_NOT_RECRUITING	—

Related Pages

All Diabetes mellitus, type 2 trials All trials in Bratislava, Slovakia